4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kiora Pharmaceuticals, Inc. (KPRX) operates in the Biotechnology industry and is headquartered in Encinitas, United States with about 13 employees. Its market capitalization is roughly $12 million. In the fiscal year ended 2025-12-31, KPRX reported $0M in revenue and ($11M) in net income.
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $16M | $0M | $0M | — |
| Operating Income (EBIT) | ($10M) | $6M | ($9M) | ($12M) | — |
| Net Income | ($11M) | $4M | ($12M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($3M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($2M) | ($6M) | $0M | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $24M | $36M | $14M | $19M | — |
| Total Liabilities | $8M | $11M | $8M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KPRX viewer.
About TickerBase · Data methodology & sources